HQY

HQY

USD

HealthEquity Inc. Common Stock

$103.250-1.260 (-1.206%)

Цена в режиме реального времени

Healthcare
Health Information Services
Соединенные Штаты

График цен

Loading Chart...

Ключевые показатели

Рыночные показатели
Фундаментальные показатели компании
Статистические данные торговли

Рыночные показатели

Открытие

$104.510

Максимум

$104.560

Минимум

$103.250

Объем

0.85M

Фундаментальные показатели компании

Рыночная капитализация

8.9B

Отрасль

Health Information Services

Страна

United States

Статистические данные торговли

Средний объем

1.26M

Биржа

NMS

Валюта

USD

52-недельный диапазон

Минимум $65.01Текущая $103.250Максимум $116.65

Связанные новости

Analyst Upgrades

Barrington Research Maintains Outperform on HealthEquity, Raises Price Target to $125

Barrington Research analyst Alexander Paris maintains HealthEquity with a Outperform and raises the price target from $112 to $125.

Просмотреть больше
Barrington Research Maintains Outperform on HealthEquity, Raises Price Target to $125
Analyst Upgrades

Deutsche Bank Maintains Buy on HealthEquity, Raises Price Target to $115

Deutsche Bank analyst George Hill maintains HealthEquity with a Buy and raises the price target from $98 to $115.

Просмотреть больше
Deutsche Bank Maintains Buy on HealthEquity, Raises Price Target to $115
Analyst Upgrades

Goldman Sachs Maintains Neutral on HealthEquity, Raises Price Target to $104

Goldman Sachs analyst David Roman maintains HealthEquity with a Neutral and raises the price target from $94 to $104.

Просмотреть больше
Goldman Sachs Maintains Neutral on HealthEquity, Raises Price Target to $104
Analyst Upgrades

RBC Capital Maintains Outperform on HealthEquity, Raises Price Target to $117

RBC Capital analyst Daniel Perlin maintains HealthEquity with a Outperform and raises the price target from $112 to $117.

Просмотреть больше
RBC Capital Maintains Outperform on HealthEquity, Raises Price Target to $117
Analyst Upgrades

B of A Securities Maintains Buy on HealthEquity, Raises Price Target to $125

B of A Securities analyst Allen Lutz maintains HealthEquity with a Buy and raises the price target from $110 to $125.

Просмотреть больше
B of A Securities Maintains Buy on HealthEquity, Raises Price Target to $125
Analyst Upgrades

JMP Securities Maintains Market Outperform on HealthEquity, Raises Price Target to $117

JMP Securities analyst Constantine Davides maintains HealthEquity with a Market Outperform and raises the price target from $110 to $117.

GlobeNewswire

HealthEquity Reports First Quarter Ended April 30, 2025 Financial Results

Highlights of the first quarter include: Revenue of $330.8 million, an increase of 15% compared to $287.6 million in Q1 FY25.Net income of $53.9 million, an increase of 87% compared to $28.8 million in Q1 FY25, with

Оставаться в курсе

Установите ценовой сигнал, получите обновления анализа ИИ и новости рынка в режиме реального времени.